Dr. Michael Stark specializes in Obstetrics and Gynecology. His main interest
is gynecological oncology. He initiated
the VIEZION project which combines targeted chemotherapy, PIF, immunology and
stem-cell therapy for improving post-surgical oncological treatment. He
modified operations like the vaginal and abdominal hysterectomy and Cesarean
Section and developed the concept of single-entry natural orifice surgery.
the years 2002-2010 he was the chairman of all the gynecological departments of
the HELIOS hospital group in Germany and Austria.
2004 he has been the President of the New European Surgical Academy (NESA), an
international inter-disciplinary surgical organization with members in 57
the years 2011-2013 he was the scientific advisor of the USP hospital in
2012-2015 he was the scientific director of the new European surgical robotic
system (TELELAP) at SOFAR company in Milan, Italy.
2016-2019 he was the scientific consultant of the ELSAN 123 hospitals in France
2011, Prof. Stark was nominated as the Medico Del Anno (Doctor of the Year) in
Italy, and is an Honorary Member of the French, Polish, Russian,
Serbian-Austrian and Italian Gynecological Associations. These days he is
professor for Robotic Surgery and Evidence Based Medicine at the university of
Adana, scientist at the Charite University Hospital in Berlin, adjunct
professor at the MIPT university in Moscow and Honorary Professor at the
University of Chisinau.
was visiting Professor at the Universities of Toronto, Moscow, Beijing, Milan,
Adana, Uppsala and the Weill-Cornell University hospital in New York.
2019 he is the vice president of the Chinese Perinatology association.